Cathinone

Cathinone

SCHEMBL34513

C[C@H](N)C(=O)c1ccccc1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
PGR P06401 1/20 0.52
ADRA2A P08913 1/20 0.52
ADRA2B P18089 1/20 0.52
HTR2A P28223 1/20 0.52
HRH1 P35367 1/20 0.52
KCNH2 Q12809 1/20 0.52
LMNA P02545 4/20 0.50
CES2 O00748 4/20 0.50
CES1 P23141 4/20 0.50
MAPT P10636 3/20 0.48
TSHR P16473 2/20 0.48
CYP3A4 P08684 2/20 0.48
POLB P06746 1/20 0.48
PARP1 P09874 1/20 0.48
CYP2C19 P33261 1/20 0.48
RECQL P46063 1/20 0.48
BLM P54132 1/20 0.48
PMP22 Q01453 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dealkylated Diethylpropion SCHEMBL25176894 1.00 TDP1 (0.52) TDP1L3MBTL1PGRADRA2AADRA2B
Dealkylated Diethylpropion SCHEMBL2236790 1.00 TDP1 (0.52) TDP1L3MBTL1PGRADRA2AADRA2B
Dealkylated Diethylpropion SCHEMBL1050427 1.00 TDP1 (0.52) TDP1L3MBTL1PGRADRA2AADRA2B
Dealkylated Diethylpropion SCHEMBL20095234 1.00 TDP1 (0.52) TDP1L3MBTL1PGRADRA2AADRA2B
Dealkylated Diethylpropion SCHEMBL1567990 0.98 TDP1 (0.50) TDP1L3MBTL1PGRADRA2AADRA2B
Cathinone SCHEMBL16429162 0.98 TDP1 (0.50) TDP1L3MBTL1PGRADRA2AADRA2B
Cathinone SCHEMBL21271204 0.92 PGR (0.55) TDP1L3MBTL1PGRADRA2AADRA2B
Hydrochloric Acid SCHEMBL9641095 0.86 SMN1; SMN2 (0.56) L3MBTL1LMNAMAPTPOLBSMN1; SMN2
Cathinone SCHEMBL25176893 0.85 L3MBTL1 (0.48) TDP1L3MBTL1PGRADRA2AADRA2B
SCHEMBL9039300 0.82 KMO (0.56) TDP1LMNAMAPTTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2136 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722714-A1 SIMULTANEOUS ANALYSIS OF FOOD-BORNE DOPING SUBSTANCES USING LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY (VFD: VACCINE FOR FOODBORNE DOPING) Korea Institute of Science and Technology (KR) 2026-04-08 EP claimed
EP-4716472-A1 POUCHED PRODUCT AND METHOD OF MAKING Imperial Tobacco Limited (GB) 2026-04-01 EP claimed
US-20260086062-A1 IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2026-03-26 US claimed
US-20260060949-A1 METHOD FOR TREATING DAMAGE INDUCED BY SLEEP DEPRIVATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2026-03-05 US claimed
US-20250271417-A1 METHOD FOR DETERMINING WHETHER A BOVINE HAS A RESPIRATORY DISEASE Agscent Pty Ltd (AU) 2025-08-28 US claimed
EP-4604743-A1 FORMULATED FOOD PRODUCTS VitaKey Inc. (US) 2025-08-27 EP claimed
EP-4590292-A1 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS Axsome Therapeutics, Inc. (US) 2025-07-30 EP claimed
US-20250216329-A1 DRUG DETECTION THE UNIVERSITY OF BATH (GB) 2025-07-03 US claimed
US-20250195465-A1 COMPOUNDS AND COMBINATIONS THEREOF FOR TREATING NEUROLOGICAL AND PSYCHIATRIC CONDITIONS AXSOME THERAPEUTICS, INC. 2025-06-19 US claimed
US-20250186510-A1 BACTERIAL COMPOSITION FOR USE IN TREATMENT OF SUBSTANCE USE DISORDER BAR-ILAN UNIVERSITY (IL) 2025-06-12 US claimed
US-20050002895-A1 Methods and compositions for controlled release of drugs WYOMING, UNIVERSITY OF, THE 2005-01-06 US claimed
WO-2004098589-A1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ELAN PHARMACEUTICALS, INC. (US) 2004-11-18 WO claimed
WO-2003051113-A1 METHODS AND COMPOSITIONS FOR CONTROLLED RELEASE OF DRUGS THE UNIVERSITY OF WYOMING (US) 2003-06-26 WO claimed
US-20020166135-A1 Modulators of the hypocretin system and methods of screening therefor SRI INTERNATIONAL 2002-11-07 US claimed
WO-2002087606-A2 MODULATORS OF THE HYPOCRETIN SYSTEM AND METHODS OF SCREENING THEREFOR SRI INTERNATIONAL (US) 2002-11-07 WO claimed
US-20020082304-A1 Denaturants for sympathomimetic amine salts MCNEIL-PPC, INC 2002-06-27 US claimed
US-6359011-B1 EFFECTIVE IN DETERRING EXTRACTION OR CONVERSION METHODS USED IN ILLEGAL DRUG PRODUCTION OF METHAMPHETAMINE FROM PSEUDOEPHEDRINE WARNER-LAMBERT COMPANY 2002-03-19 US claimed
CN-1316911-A Compositions containing sympathomimetic amine salts not suitable for illicit use WARNER LAMBERT CO (US) 2001-10-10 CN claimed
EP-1112089-A1 COMPOSITIONS COMPRISING SYMPATHOMIMETIC AMINE SALTS UNSUITABLE FOR ILLEGAL USE WARNER-LAMBERT COMPANY (US) 2001-07-04 EP claimed
WO-2000015261-A1 COMPOSITIONS COMPRISING SYMPATHOMIMETIC AMINE SALTS UNSUITABLE FOR ILLEGAL USE WARNER-LAMBERT COMPANY (US) 2000-03-23 WO claimed